Down-regulation of miR-34a Expression in Cervical Intraepithelial Neoplasia with Human Papillomavirus Infection and Its Relationship with p53 Expression

  • Lee, Kyung Eun (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan)
  • Received : 2013.08.26
  • Accepted : 2013.12.27
  • Published : 2013.12.31

Abstract

microRNAs (miRNAs) play pivotal roles in controlling cell proliferation and differentiation. miRNA expression in human is becoming recognized as a new molecular mechanism of carcinogenesis. microRNA-34a (miR-34a), a member of the p53 network, was found to be regulated in multiple types of tumor. The purpose of this study was to define roles of miR-34a expression in cervical intraepithelial neoplasia with human papillomavirus infection, and its relationship with p53 protein expression. This study was performed to analyze expression of miR-34a by using qRT-PCR, and to evaluate p53 protein expression by using immunohistochemistry in 40 cases. Down-regulation of miR-34a expression was detected in 27 (67.5%) out of 40 cases and Immunoreactivity for p53 was found in 17 (42.5%) out of 40 cases. Nineteen (82.6%) of the 23 cases with a negative p53 expression showed a down-regulation miR-34a expression, there was a significant associations between miR-34a and p53 protein expression (P=0.04). These results suggest that miRNA-34a expression tend to be reduced depending on the advanced histologic grade, and down-regulation of miR-34a expression might be associated with inactivation of p53 protein expression by human papillomavirus infection.

Keywords

References

  1. Benchimol S, Lamb P, Crawford LV, Shows TB, Bruns GA. Transformation associated p53 protein is encoded by a gene on human chromosome 17. Somatic Cell Mol Genet. 1985. 11: 505-509. https://doi.org/10.1007/BF01534845
  2. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006. 6: 857-866. https://doi.org/10.1038/nrc1997
  3. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M,Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007. 26: 745-752. https://doi.org/10.1016/j.molcel.2007.05.010
  4. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 1988. 57: 1083-1086.
  5. Herrington CS. Human papillomaviruses and cervical neoplasia.II. Interaction of HPV with other factors. J Clin Pathol. 1995. 48: 1-6. https://doi.org/10.1136/jcp.48.1.1
  6. Ji Q, Hao X, Zhang M, Tang W, Yang M, Li L, Xiang D, Desano JT, Bommer GT, Fan D, Fearon ER, Lawrence TS, Xu L. MicroRNA miR-34 inhibits human pancreatic cancer tumorinitiating cells. PLoS One. 2009. 4: e6816. https://doi.org/10.1371/journal.pone.0006816
  7. Kim MY, Cho SH, Park MH. Analysis of expression of p63 in cervical neoplasia comparing with other immunohistochemical markers. Korean J Pathol. 2003. 37: 333-341.
  8. Kivi N, Greco D, Auvinen P, Auvinen E. Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression. Oncogene. 2008. 27: 2532-2541. https://doi.org/10.1038/sj.onc.1210916
  9. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007. 39: 673-677. https://doi.org/10.1038/ng2003
  10. Levin AJ, Momandd J, Finlay CA. The p53 tumor supressor gene. Nature. 1991. 351: 453-456. https://doi.org/10.1038/351453a0
  11. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, Korner H, Knyazev P, Diebold J, Hermeking H. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle. 2008. 7: 2591-2600. https://doi.org/10.4161/cc.7.16.6533
  12. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature. 2005. 435: 834-838. https://doi.org/10.1038/nature03702
  13. Ma L, Weinberg RA. MicroRNAs in malignant progression. Cell Cycle. 2007. 7: 570-572.
  14. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol. 2000. 151: 1158-1171. https://doi.org/10.1093/oxfordjournals.aje.a010166
  15. Park IS, Han HS, Kim TS. Immunohistochemical expression of p53, p21, and mdm2 proteins in human papillomavirus positive and negative invasive uterine cervical carcinomas. Korean J Pathol. 2001. 35: 212-219.
  16. Pinto AP, Crum CP. Natural history of cervical neoplasia: defining progression and its consequence. Clin Obstet Gynecol. 2000. 43: 352-362. https://doi.org/10.1097/00003081-200006000-00015
  17. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV- 16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 1993. 75: 495-505. https://doi.org/10.1016/0092-8674(93)90384-3
  18. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature. 2009. 460: 529-533. https://doi.org/10.1038/nature08199
  19. Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, Broker TR, Meyers C, Chow LT, Zheng ZM. Oncogenic HPV infection interrupts the expression of tumor-suppressive miR- 34a through viral oncoprotein E6. RNA. 2009. 15: 637-647. https://doi.org/10.1261/rna.1442309
  20. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA. 2008. 105: 13421-13426. https://doi.org/10.1073/pnas.0801613105
  21. Zheng ZM, Wang X. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta. 2011. 1809: 668-677. https://doi.org/10.1016/j.bbagrm.2011.05.005